Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases

Juan Zhou, Fei Zhou, Xiangling Chu, Jing Zhao, Yan Wu, Wencheng Zhao, Chuan Xu, Chunxia Su